Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interVentional, multI-center and longiTudinAL Study to Describe the Use of SodIum Zirconium CyclosilicatE (LokelmaTM) in Patients Diagnosed With Hyperkalemia in the Real-world Setting in Spain: VITALIZE Study

NCT06635499 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06635499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06635499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interVentional, multI-center and longiTudinAL Study to Describe the Use of SodIum Zirconium CyclosilicatE (LokelmaTM) in Patients Diagnosed With Hyperkalemia in the Real-world Setting in Spain: VITALIZE Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 13, 2024
Completion date
May 20, 2025
Enrollment
232 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

hyperkalaemia